Prof. Pramod Nehete | Non-Human primates Award | Most Cited Article Award
Professor at UT MD Anderson cancer center, United States
π¨βπ¬ Dr. Pramod N. Nehete, PhD, is a distinguished Professor at the Michale E. Keeling Center for Comparative Medicine and Research, UT MD Anderson Cancer Center. π With a Ph.D. in Biochemistry and extensive experience in comparative medicine, his expertise spans immunology, HIV research, and vaccine development. π§ͺ Dr. Nehete is renowned for his pioneering work on nanochannel drug delivery systems for HIV treatment in non-human primates. π His accolades include prestigious fellowships and memberships in esteemed scientific societies. π Dr. Neheteβs commitment to advancing medical science is evident through his editorial roles and grant review activities. His research interests encompass immunotherapy, infectious diseases, and translational medicine. π§¬
Profile
π Education
Dr. Nehete holds a Ph.D. in Biochemistry from the University of Poona, India, along with an M.S. in Biochemistry and a B.S. in Biology/Chemistry from esteemed Indian universities. π His academic journey laid the foundation for his illustrious career in biomedical research. π§¬
π¨βπΌ Experience
With over two decades of service at UT MD Anderson Cancer Center, Dr. Nehete has contributed significantly to comparative medicine and translational molecular pathology. π₯ He has led numerous research projects, focusing on HIV treatment and vaccine development, demonstrating his expertise in GLP studies and flow cytometry. π
π¬ Research Interests
Dr. Neheteβs research interests revolve around immunotherapy, infectious diseases, and vaccine development. π¦ He is particularly passionate about leveraging animal models to study HIV/AIDS and emerging infectious diseases like Zika virus. π
π Awards
Dr. Nehete has received prestigious fellowships and scholarships, recognizing his outstanding contributions to biomedical research. π His dedication to scientific excellence has earned him recognition from the Government of India and the Center for Scientific and Industrial Research. π
Publications Top Notes
Changes in local tissue microenvironment in response to subcutaneous long-acting delivery of tenofovir alafenamide in rats and non-human primatesβ (2023)
βLong-acting refillable nanofluidic implant confers protection against SHIV infection in nonhuman primatesβ (2023)
βImplantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal in ratsβ (2022)
βExtending Drug Release from Implants via Transcutaneous Refilling with Solid Therapeuticsβ (2022)
βUltra-long acting prodrug of dolutegravir and delivery system β Physicochemical, pharmacokinetic and formulation characterizationsβ (2021)
βInnate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimerβs disease pathology in aged squirrel monkeysβ (2021)
βPreventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV-Challenged Nonhuman Primatesβ (2021)